loadpatents
Patent applications and USPTO patent grants for SciClone Pharmaceuticals International Ltd..The latest application filed is for "use of thymosin alpha for the treatment of sepsis".
Patent | Date |
---|---|
Use Of Thymosin Alpha For The Treatment Of Sepsis App 20210106656 - GUAN; Xiangdong ;   et al. | 2021-04-15 |
Treatment Of Cancer With Immune Stimulators App 20200289618 - KING; Robert S. ;   et al. | 2020-09-17 |
Thymosin Alpha 1 For Use In Treatment Of Cystic Fibrosis App 20200023039 - ROMANI; Luigina ;   et al. | 2020-01-23 |
Thymosin alpha 1 for use in treatment of cystic fibrosis Grant 10,478,474 - Romani , et al. Nov | 2019-11-19 |
Use of thymosin alpha 1 for preparing a medicament for the treatment of stage IV malignant melanoma Grant 8,017,129 - Carminati , et al. September 13, 2 | 2011-09-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.